Home/Pipeline/RZ-629

RZ-629

Obesity & Diabetes

Phase 1Active

Key Facts

Indication
Obesity & Diabetes
Phase
Phase 1
Status
Active
Company

About Rezubio

Rezubio develops gut-restricted drugs using its Membrane-Anchored Drug Design platform to create safer, more effective treatments for metabolic and inflammatory diseases.

View full company profile

Other Obesity & Diabetes Drugs

DrugCompanyPhase
LY3437943Eli LillyPhase 2